ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China · Delayed Price · Currency is CNY 33.82
+0.87 (2.64%)
At close: Feb 3, 2026
SHE:300723 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -429.58 | -540.04 | 184.61 | 290.68 | 306.92 | 225.61 |
Depreciation & Amortization | 198.4 | 198.4 | 182.2 | 97.45 | 73.47 | 40.68 |
Other Amortization | 29.68 | 29.68 | 17.92 | 16.07 | 10.95 | 0.84 |
Loss (Gain) From Sale of Assets | -1.27 | -1.27 | -0.12 | -0.19 | 0.07 | -0.03 |
Asset Writedown & Restructuring Costs | 26.88 | 26.88 | 1.02 | 0.45 | 1.34 | 2.92 |
Loss (Gain) From Sale of Investments | 40.11 | 40.11 | 24.64 | 28.31 | -45.46 | -13.19 |
Provision & Write-off of Bad Debts | 1.3 | 1.3 | 3.49 | 1.68 | 0.99 | - |
Other Operating Activities | 114.36 | 23.39 | 7.24 | 0.74 | 30.41 | 9.77 |
Change in Accounts Receivable | 20.93 | 20.93 | -12.6 | -187.23 | 76.75 | 6.96 |
Change in Inventory | 45.04 | 45.04 | -168.41 | -63.05 | -2.67 | -28.41 |
Change in Accounts Payable | -308.97 | -308.97 | 244.94 | 295.05 | -27.81 | 34.2 |
Change in Other Net Operating Assets | 2.44 | 2.44 | -10.79 | 15.81 | 13.79 | -8.03 |
Operating Cash Flow | -349 | -550.42 | 458.05 | 475.53 | 438.1 | 275.22 |
Operating Cash Flow Growth | - | - | -3.68% | 8.54% | 59.18% | -1.93% |
Capital Expenditures | -118.41 | -319.76 | -334.46 | -605.78 | -561.23 | -314.15 |
Sale of Property, Plant & Equipment | 0.17 | 0.07 | 0.05 | 0.25 | 0.06 | 0.03 |
Cash Acquisitions | - | - | - | - | -46.28 | -5.33 |
Investment in Securities | -106.53 | 36.75 | -353.69 | -79.76 | -340.26 | -1.4 |
Other Investing Activities | 12.17 | 7.94 | 109.11 | 15.77 | 28.13 | 13.68 |
Investing Cash Flow | -212.61 | -275 | -578.99 | -669.53 | -919.59 | -307.17 |
Short-Term Debt Issued | - | - | - | - | - | 307.21 |
Long-Term Debt Issued | - | 1,970 | 1,100 | 1,200 | 1,300 | - |
Total Debt Issued | 2,207 | 1,970 | 1,100 | 1,200 | 1,300 | 307.21 |
Short-Term Debt Repaid | - | - | - | - | - | -220.57 |
Long-Term Debt Repaid | - | -1,079 | -1,128 | -1,332 | -317.5 | - |
Total Debt Repaid | -1,768 | -1,079 | -1,128 | -1,332 | -317.5 | -220.57 |
Net Debt Issued (Repaid) | 438.69 | 890.69 | -27.99 | -132.35 | 982.58 | 86.64 |
Issuance of Common Stock | 57.66 | 57.66 | 7.28 | - | 35.04 | - |
Repurchase of Common Stock | -22.37 | -22.37 | -0.31 | -41.65 | -123.27 | -36.52 |
Common Dividends Paid | -32.06 | -108.21 | -66.04 | -63.61 | -39.6 | -36.83 |
Other Financing Activities | 19.37 | -1.77 | 186.81 | 98.71 | -298.94 | 3.49 |
Financing Cash Flow | 461.29 | 816 | 99.76 | -138.9 | 555.81 | 16.78 |
Foreign Exchange Rate Adjustments | 0.98 | 1.31 | -2.39 | 0.1 | -0.47 | - |
Net Cash Flow | -99.34 | -8.11 | -23.57 | -332.79 | 73.84 | -15.17 |
Free Cash Flow | -467.41 | -870.18 | 123.59 | -130.25 | -123.13 | -38.93 |
Free Cash Flow Margin | -45.63% | -60.00% | 4.94% | -5.71% | -5.60% | -2.32% |
Free Cash Flow Per Share | -1.03 | -1.93 | 0.27 | -0.30 | -0.29 | -0.09 |
Cash Income Tax Paid | 62.67 | 270.13 | 353.37 | 219.43 | 280.98 | 252.33 |
Levered Free Cash Flow | -240.33 | -401.11 | 13.79 | -228.71 | -267.83 | -144.5 |
Unlevered Free Cash Flow | -207.05 | -379.17 | 37.33 | -210.61 | -243.77 | -137.16 |
Change in Working Capital | -328.88 | -328.88 | 37.05 | 40.33 | 59.43 | 8.62 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.